SOM Biotech had the opportunity to present SOM3355 program for Huntington’s disease during the XIII Pharma-Biotech Cooperation Sessions organized by FARMAINDUSTRIA. Barcelona, October 20th 2015.

For further information please visit medicamentos innovadores.

SUBCRIBE TO OUR NEWSLETTER

    Name*
    Email*


    I confirm that by completing this form I have used only personal data about myself and that they are true and up-to-date.
    SOM INNOVATION BIOTECH, S.A. is responsible for the processing of my personal data to manage the newsletter service requested through the form, as well as to track the receipt of these through tracking technologies. The Privacy Policy tells me how I can exercise my rights of access, rectification, deletion, limitation, portability and opposition.